Recombinant Dog Bcl-2-like Protein 2 Protein，His

Bcl-2-like protein 2 (Bcl2L2), a member of the Bcl-2 family, plays a crucial role in the regulation of apoptosis and cell survival. Its primary function is to promote cell survival by inhibiting programmed cell death, making it a significant factor in various physiological and pathological processes, including cancer, neurodegenerative diseases, and immune responses. Research has shown that overexpression of Bcl2L2 is associated with tumorigenesis and resistance to chemotherapy, positioning it as a potential therapeutic target. Given its importance, the study of recombinant Bcl2L2 proteins has garnered attention for understanding the protein's structure, function, and interaction with other apoptotic regulators. Recombinant expression systems, such as bacterial or yeast systems, are often employed to produce functional Bcl2L2 proteins, allowing for the investigation of its biochemical properties and the development of Bcl2L2 inhibitors. Exploring these recombinant proteins can lead to insights into apoptotic pathways and the design of novel drugs aimed at reversing the anti-apoptotic effects of Bcl2L2 in cancer cells. The ongoing research highlights the potential of targeting Bcl2L2 as a therapeutic strategy to enhance the efficacy of existing treatments and improve clinical outcomes in malignancies characterized by elevated Bcl2L2 levels.